Lewis TD, Malik M, Britten J, San Pablo AM, Catherino WH
Metabolik srelerin ynetimi ve performans artrm, sadece takviye kullanmyla deil, bilimsel bir salk stratejisiyle mmkn olur
Although these agents produce substantial and sustained weight reduction, emerging clinical observations suggest that chronic therapy may be accompanied by changes in lean mass trajectory, reduced protein intake, and micronutrient insufficiency
Clinical studies have shown impressive results: Semaglutide Average weight loss: 1215% of body weight Tirzepatide Average weight loss: 1822% of body weight Many patients lose 1025 kg over 1218 months when combined with healthy eating and physical activity
For thousands of people in 2026, that perfect balance is not only possibleit's finally within reach
Vitamin B12 deficiency is particularly relevant in older patients and in anyone taking metformin concurrently, as metformin is known to reduce B12 absorption